MwanzoORCHPHARMA • NSE
add
Orchid Pharma Ltd
Bei iliyotangulia
₹ 808.55
Bei za siku
₹ 805.05 - ₹ 848.95
Bei za mwaka
₹ 684.35 - ₹ 1,997.40
Thamani ya kampuni katika soko
42.63B INR
Wastani wa hisa zilizouzwa
elfu 95.38
Uwiano wa bei na mapato
38.42
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 2.17B | -1.47% |
Matumizi ya uendeshaji wa biashara | 747.93M | 3.12% |
Mapato halisi | 207.75M | -29.41% |
Kiwango cha faida halisi | 9.56 | -28.34% |
Mapato kwa kila hisa | — | — |
EBITDA | 257.00M | -35.44% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 2.44B | 384.25% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 12.24B | — |
hisa zilizosalia | 50.67M | — |
Uwiano wa bei na thamani | 3.35 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 3.20% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 207.75M | -29.41% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Orchid Pharma Limited is an Indian pharmaceutical chimpanzee based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Ilianzishwa
1992
Tovuti
Wafanyakazi
871
